SEARCH

SEARCH BY CITATION

References

  • 1
    Aschbacher R, Doumith M, Livermore DM, Larcher C, Woodford N. Linkage of acquired quinolone resistance (qnrS1) and metallo-β-lactamase (blaVIM-1) in multiple species of Enterobacteriaceae from Bolzano, Italy. J Antimicrob Chemother 2008; 61: 515523.
  • 2
    March A, Aschbacher R, Dhanji H et al. Colonization of residents and staff of a long-term care facility and adjacent acute-hospital geriatric unit by multi-resistant bacteria. Clin Microbiol Infect 2009; Aug 17 [Epub ahead of print]. DOI: 10.1111/j.1469-0691.2009.03024.x.
  • 3
    Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440458.
  • 4
    Maltezou HC. Metallo-β-lactamases in gram-negative bacteria: introducing the era of pan-resistance? Int J Antimicrob Agents 2008; 33: 405. e1–7.
  • 5
    Luzzaro F, Docquier JD, Colinon C et al. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid. Antimicrob Agents Chemother 2004; 48: 648650.
  • 6
    Rossolini GM, Luzzaro F, Migliavacca R et al. First countrywide survey of acquired metallo-β-lactamases in gram-negative pathogens in Italy. Antimicrob Agents Chemother 2008; 52: 40234029.
  • 7
    Perilli M, Mezzatesta ML, Falcone M et al. Class I integron-borne blaVIM-1 carbapenemase in a strain of Enterobacter cloacae responsible for a case of fatal pneumonia. Microb Drug Resist 2008; 14: 4547.
  • 8
    Cagnacci S, Gualco L, Roveta S et al. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-β-lactamase: first Italian outbreak. J Antimicrob Chemother 2008; 61: 296300.
  • 9
    Castanheira M, Debbia E, Marchese A, Jones RN. Emergence of a plasmid mediated blaVIM-1 in Citrobacter koseri: report from the SENTRY antimicrobial surveillance program (Italy). J Chemother 2009; 21: 98100.
  • 10
    Falcone M, Perilli M, Mezzatesta L et al. Prolonged bacteraemia caused by VIM-1 metallo-β-lactamase-producing Proteus mirabilis: first report from Italy. Clin Microbiol Infect 2010; 16: 179181.
  • 11
    Falcone M, Mezzatesta ML, Perilli M et al. VIM-1 metallo-β-lactamase producing Enterobacter cloacae infections and their correlation with clinical outcome. J Clin Microbiol 2009; 47: 35143519.
  • 12
    Yigit H, Queenan AM, Anderson GJ et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 11511161.
  • 13
    Andrews JM. BSAC standardized disc susceptibility testing method (version 6). J Antimicrob Chemother 2007; 60: 2041.
  • 14
    Pirofski LA, Casadevall A. The meaning of antimicrobial exposure, infection, colonization, and disease in clinical practice. Lancet 2002; 2: 628635.
  • 15
    Kaufmann ME. Pulsed-field gel electrophoresis. In: WoodfordN, JohnsonAP, eds, Molecular biology: protocols and clinical applications. Totowa, NJ: Humana Press, 1998; 3350.
  • 16
    Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 22332239.
  • 17
    Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 2006; 57: 154155.
  • 18
    Poirel L, Naas T, Nicolas D et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2001; 44: 891897.
  • 19
    Yan JJ, Hsueh PR, Ko WC et al. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 gene. Antimicrob Agents Chemother 2001; 45: 22242228.
  • 20
    Hata M, Suzuki M, Matsumoto M et al. Cloning of the novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 2005; 49: 801803.
  • 21
    Yuan M, Aucken H, Hall LM, Pitt TL, Livermore DM. Epidemiological typing of klebsiellae with extended-spectrum β-lactamases from European intensive care units. J Antimicrob Chemother 1998; 4: 527539.
  • 22
    Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981; 145: 13651373.
  • 23
    Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219228.
  • 24
    Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 45554558.
  • 25
    Pomba C, Mendonça N, Costa M et al. Improved multiplex PCR method for the rapid detection of β-lactamase genes in Escherichia coli of animal origin. Diagn Microbiol Infect Dis 2006; 56: 103106.
  • 26
    Deshpande LM, Jones RN, Fritsche TR, Sader HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY antimicrobial surveillance program (2000-2004). Microb Drug Resist 2006; 4: 223230.
  • 27
    Daikos GL, Petrikkos P, Psichogiou M et al. Prospective observational study of the impact of VIM-1 metallo-β-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 2009; 53: 18681873.
  • 28
    Souli M, Kontopidou FV, Papadomichelakis E et al. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek University Hospital. Clin Infect Dis 2008; 46: 847854.
  • 29
    Loli A, Tsouvelekis LS, Tzelepi E et al. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1. J Antimicrob Chemother 2006; 58: 669672.
  • 30
    Psichogiou M, Tassios PT, Avlamis A et al. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother 2008; 61: 5963.
  • 31
    Huletsky A, Knox JR, Levesque RC. Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type β-lactamases probed by site-directed mutagenesis and three-dimensional modelling. J Biol Chem 1993; 268: 36903697.
  • 32
    Cerquetti M, García-Fernández A, Giufrè M et al. First report of plasmid-mediated quinolone resistance determinant qnrS1 in Escherichia coli of animal origin in Italy. Antimicrob Agents Chemother 2009; 53: 31123114.
  • 33
    Wu JJ, Ko WC, Tsai SH, Yan JJ. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother 2007; 51: 12231227.